Prof. Ying Liao | Animal virus | Best Researcher Award

Published on by Infectious

Prof. Ying Liao | Animal virus | Best Researcher Award

Shanghai Veterinary Research Institute, Chinese Academy of Agricultutral Science | China.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Prof. Ying Liao began her academic journey with a B.Sc. from East China Normal University (1993–1997), laying the groundwork for her passion in molecular virology and infectious diseases. She further honed her expertise through a Ph.D. in Biological Sciences at Nanyang Technological University, Singapore (2002–2007), where she embarked on groundbreaking research into coronavirus biology and viral-host interactions, setting the tone for a stellar scientific career.

💼PROFESSIONAL ENDEAVORS

Prof. Liao’s professional path reflects her unwavering commitment to virology research and leadership. She held research fellow positions at both Nanyang Technological University and the Institute of Molecular and Cell Biology, A*STAR Singapore, between 2007–2014. In 2014, she joined the Shanghai Veterinary Research Institute (SHVRI) of the Chinese Academy of Agricultural Sciences (CAAS) as a Professor, where she currently serves as Group Leader and Principal Investigator of the Avian Viral Diseases Team. Her team is central to China’s national strategy on animal infectious disease control and vaccine innovation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL VIRUS

Prof. Ying Liao’s research centers on animal virus pathogenesis, especially coronaviruses, flaviviruses, and paramyxoviruses. Her work has made significant contributions in:

  • Understanding virus-host molecular mechanisms

  • Dissecting immune evasion pathways

  • Developing diagnostic tools and antiviral therapeutics

  • Exploring translational control during infection

Her team uses coronavirus and paramyxovirus models to study innate immunity suppression, stress granule manipulation, and translation shutoff, delivering insights that are not only academically profound but also clinically and agriculturally impactful.

🌍IMPACT AND INFLUENCE

Prof. Liao’s discoveries have broad implications in the fields of veterinary virology, pandemic preparedness, and vaccine design. Her research has informed global scientific understanding of zoonotic diseases and has contributed directly to the development of protective vaccines and antiviral strategies against infectious bronchitis virus (IBV) and Newcastle Disease Virus (NDV). As an internationally respected virologist, she continues to collaborate with leading figures across Asia, Europe, and the Americas, enhancing One Health frameworks worldwide.

🏆RESEARCH GRANTS AND FUNDING

Prof. Ying Liao has successfully led and secured over 12 major research grants, including:

  • 🇨🇳 National Natural Science Foundation of China (NSFC)

  • 🧬 National Key R&D Program of China

  • 🧪 Shanghai Natural Science Foundation

  • 🏛 Chinese Academy of Agricultural Sciences (CAAS) Elite Youth Program

  • 🔬 Public-Interest Scientific Institution Basal Research Fund

Collectively, these projects total millions in funding, empowering extensive research into coronavirus immune evasion, host translation shutoff, stress granules, and avian vaccine development.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Prof. Liao is shaping the future of infectious disease research in China and beyond. Her legacy includes:

  • The development of a cell line expressing furin protein for avian coronavirus culture (patented)

  • The training and mentorship of numerous postdoctoral researchers and graduate students

  • Significant strides toward universal vaccine strategies for coronaviruses

  • Leadership in the design of molecular diagnostic reagents for rapid outbreak response

Her dedication ensures that her work will outlive current global health challenges and serve as a foundation for next-generation viral therapeutics.

🌟A VISIONARY IN INFECTIOUS DISEASES

A trailblazer in veterinary and molecular virology, Prof. Ying Liao embodies the rare blend of scientific excellence, innovative thinking, and societal relevance. Her relentless pursuit of knowledge in host-pathogen interactions, vaccine innovation, and immune regulation has solidified her role as a visionary leader in infectious diseases. Her strategic foresight and collaborative mindset continue to transform how the scientific community responds to animal and zoonotic viral threats.

📑NOTABLE PUBLICATIONS

🧪Coronavirus endoribonuclease nsp15 suppresses host protein synthesis and evades PKR-eIF2α-mediated translation shutoff to ensure viral protein synthesis

Authors: Gong, Xiaoqian; Feng, Shanhuan; Wang, Jiehuang; Forlenza, Maria; Liao, Ying
Year: 2025
Journal: PLoS Pathogens

🧪Targeting host integrated stress response: lead discovery of flavonoid compounds active against coronaviruses PEDV and PDCoV

Authors: Yi, Liang; Wang, Yishuai; Wang, Jiehuang; Liao, Ying; Zhang, Qingwen
Year: 2024
Journal: RSC Medicinal Chemistry

🧪Newcastle disease virus infection induces parthanatos in tumor cells via calcium waves

Authors: Qu, Yang; Wang, Siyuan; Jiang, Hui; Sun, Yingjie; Ding, Chan
Year: 2024
Journal: PLoS Pathogens

🧪 Coronavirus nucleocapsid protein enhances the binding of p-PKCα to RACK1: Implications for inhibition of nucleocytoplasmic trafficking and suppression of the innate immune response

Authors: Xue, Wenxiang; Chu, Hongyan; Wang, Jiehuang; Ding, Chan; Liao, Ying
Year: 2024
Journal: PLoS Pathogens

🧪FGFR1-mediated enhancement of foot-and-mouth disease virus entry

Authors: Wang, Xuefei; Liao, Ying; Abdullah, Sahibzada Waheed; Sun, Shiqi; Guo, Huichen
Year: 2024
Journal: Veterinary Microbiologyy

Dr. Jialin Wang | Immunity | Best Researcher Award

Published on by Infectious

Dr. Jialin Wang | Immunity | Best Researcher Award

Central China Normal University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Dr. Jialin Wang began his academic journey with a Bachelor of Science in Biology from Anhui Normal University (2000–2004), where he laid the foundational knowledge in life sciences. He further specialized by obtaining his Ph.D. in Biochemistry and Molecular Biology from Shandong University in 2009. His doctoral research ignited a lifelong focus on molecular immunology and insect biology, providing the groundwork for a highly productive scientific career.

💼PROFESSIONAL ENDEAVORS

Dr. Wang’s professional career has been rooted at the School of Life Sciences, Central China Normal University in Wuhan, China. He was appointed as an Assistant Professor (2009–2012) and later promoted to Associate Professor (2012–present). His international academic exposure includes visiting scholar positions at the University of California, Riverside (2015–2016, 2019–2020), and a stint as a Research Assistant at The University of Hong Kong (2012). These experiences expanded his expertise in insect molecular biology and comparative immunology.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNITY

Dr. Wang has built a distinguished research portfolio centered on:

  • 🦋 Insect innate immunity

  • 🧠 Endocrine-immune system interactions

  • 🧬 Molecular regulation of immune genes by hormones such as 20-hydroxyecdysone (20E)

  • 🛡️ Pattern recognition receptors (PRRs) and cellular/humoral immune responses

His work particularly shines in elucidating the cross-talk between endocrine signals and immune defense mechanisms in model pests like Helicoverpa armigera and Spodoptera frugiperda. His studies reveal how steroid hormones modulate immune responses, offering new targets for pest control.

.

🌍IMPACT AND INFLUENCE

With over 20+ high-impact publications, Dr. Wang’s findings are contributing to global understanding of insect immune biology, paving the way for:

  • 🌾 Sustainable agricultural pest management

  • 🧪 Bioengineering of immune-regulatory pathways

  • 🌐 Cross-species immunological insights relevant to infectious disease modeling

His international collaborations, notably with scientists like Dr. Alexander S. Raikhel, have placed his research within the global framework of vector-borne disease control and immunity studies.

🏆RESEARCH GRANTS AND FUNDING

Dr. Wang has successfully led and contributed to multiple competitive national and provincial projects, totaling millions in RMB funding. His grants include:

  1. 🧬 NSFC #32470517 (2025–2028): Gut immunity & metamorphosis in Helicoverpa armigera.

  2. 🔍 NSFC #31872301 (2019–2022): Hemocytic encapsulation regulated by PRPs and 20E.

  3. 💡 NSFC #31101672 (2012–2014): Immune gene identification post-20E treatment.

  4. 🌿 Hubei Foundation #2016CFB560 & 2010CDB01204: Functional analysis of C-type lectins & novel insecticide targets.

These projects emphasize his expertise in immune-endocrine dynamics and his drive to develop eco-friendly pest control solutions.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Wang’s scholarly output reflects a systematic deconstruction of insect immunity at the molecular level. By pioneering studies on C-type lectins, PRRs, and hormone-immune regulation, he has built a foundation for future innovations in:

  • 🦠 Host-pathogen interaction modeling

  • 🌾 Biological pest control strategies

  • 🧪 Synthetic biology applications in immunology

He is mentoring the next generation of researchers, and his legacy is marked by a vision of biological control that respects ecological integrity.

🌟A VISIONARY IN INFECTIOUS DISEASES

By decoding the molecular choreography between hormones and immunity in insects, Dr. Wang contributes to broader insights into infectious disease resistance, vector control, and immunological adaptation. His findings may one day aid in understanding pathogen manipulation of host immune systems across species.

📑NOTABLE PUBLICATIONS

The ecdysone-induced bZIP transcription factor MafB establishes a positive feedback loop to enhance vitellogenesis and reproduction in the Aedes aegypti mosquito

Authors: Jialin Wang, Ziqian Zhong, Yazhou He, Yufeng Wang, Alexander S. Raǐkhel
Year: 2025
Journal: Proceedings of the National Academy of Sciences of the United States of America (PNAS)
Citations: 2​

A CTL − Lys immune function maintains insect metamorphosis by preventing gut bacterial dysbiosis and limiting opportunistic infections

Authors: Pei Xiong, Wenwen Wang, Xusheng Liu, Yufeng Wang, Jialin Wang
Year: 2024
Journal: BMC Biology
Citations: 1​

An entomopathogenic fungus exploits its host humoral antibacterial immunity to minimize bacterial competition in the hemolymph

Authors: Jialin Wang, Jing Sun, Ya Jing Song, Li Li, Xusheng Liu
Year: 2023
Journal: Microbiome
Citations: 15

Dr. Amanda Rodriguez Betancourt | Surgical Site Infections | Best Researcher Award

Published on by Infectious

Dr. Amanda Rodriguez Betancourt | Surgical Site Infections | Best Researcher Award

UNIVERSITY OF ILLINOIS AT CHICAGO | United States.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Dr. Amanda Beatriz Rodriguez Betancourt began her academic journey with a Doctor of Dental Surgery (DDS) degree from Universidad Santa María in Venezuela. With a profound interest in periodontology and surgical precision, she later pursued a Master of Science in Periodontics from the prestigious Pontificia Universidad Javeriana, Colombia. Her early education laid the groundwork for a dynamic career that seamlessly merges clinical excellence, scientific rigor, and a deep commitment to patient-centered care.

💼PROFESSIONAL ENDEAVORS

Dr. Rodriguez Betancourt has held notable roles in both academic and clinical settings across Latin America and the United States. She served as Assistant Program Director and Research Fellow in the Graduate Periodontics Program at the University of Michigan, where she also co-directed the Periodontal, Implant, and Microsurgery Academy (PiMA). She is currently advancing her training through a Master’s in Oral Sciences and a Certificate in Periodontics at the University of Illinois Chicago (UIC).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON SURGICAL SITE INFECTIONS

A key area of Dr. Rodriguez Betancourt’s scholarly contributions is Surgical Site Infections (SSIs) within periodontology and implantology. Her research delves into early-stage detection, wound healing dynamics, and tissue perfusion assessments using Laser Speckle Contrast Imaging (LSCI) and 3D intraoral scanning. By integrating ultrasound imaging, CBCT-guided planning, and CAD/CAM technology, her studies aim to minimize post-operative complications, particularly SSIs, in both soft- and hard-tissue surgical sites. These efforts are helping redefine protocols for infection control, minimally invasive surgery, and clinical decision-making in complex periodontal cases.

🌍IMPACT AND INFLUENCE

Dr. Rodriguez Betancourt’s work has influenced both clinical and academic communities through her interdisciplinary collaborations, translational research, and dedication to evidence-based dentistry. Her expertise in imaging-driven diagnostics and microsurgical techniques has directly impacted peri-implant therapy, graft survival, and SSI prevention protocols. She is recognized for advancing a precision-medicine approach in periodontology, promoting personalized care grounded in digital data.

🏆RESEARCH GRANTS AND FUNDING

While serving at the University of Michigan, Dr. Rodriguez Betancourt contributed to NIH-funded studies exploring the pathophysiology of periodontitis and implant-associated infections. She has participated in multi-center clinical trials and currently engages in grant-supported research at UIC, focusing on oral tissue response to biomaterials and novel imaging for surgical monitoring.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Rodriguez Betancourt’s legacy is rooted in her commitment to translational research, cross-disciplinary education, and clinical innovation. Her future goals include leading global collaborations to develop standardized imaging protocols for early SSI detection and shaping next-generation training curricula in periodontal diagnostics and infection control. She envisions a future where digital health technologies empower dentists to detect infections before clinical symptoms emerge.

🌟A VISIONARY IN INFECTIOUS DISEASES

Through her visionary work, Dr. Amanda Rodriguez Betancourt stands at the intersection of periodontal surgery and infectious disease research. Her pursuit of innovation, clinical excellence, and academic mentorship underscores her role as a transformative leader in dental medicine. Her mission is clear: to elevate global standards in oral health, reduce post-surgical infection rates, and bring cutting-edge science into the hands of everyday clinicians.

📑NOTABLE PUBLICATIONS

🧪Introduction of “MAPS” Wound Healing Index and Its Correlation with Guided Bone Regeneration Outcome

Authors: Amanda Rodriguez, Tanay Chaubal, Diego Velasquez, Leonardo Marquez, Jose Maria Ramos, Nataly Zambrana, Maria Masotti, Oliver Kripfgans, Hsun-Liang Chan
Year: 2025
Journal: PLOS ONE

🧪Minimally Invasive Sinus Augmentation: A Systematic Review

Authors: Benyapha Sirinirund, Amanda B. Rodriguez Betancourt, Riccardo Scaini, Yu‐Chang Wu, Hsun‐Liang Chan
Year: 2025
Journal: Clinical Implant Dentistry and Related Research

🧪Ultrasound‐Based Jawbone Surface Quality Evaluation After Alveolar Ridge Preservation

Authors: Amanda B. Rodriguez, Oliver D. Kripfgans, Kenneth M. Kozloff, Ankita Samal, Jae‐man Woo, Mostafa Shehabeldin, Hsun‐Liang Chan
Year: 2024
Journal: Journal of Periodontology

🧪The Use of Digital Technologies in Peri‐Implant Soft Tissue Augmentation – A Narrative Review on Planning, Measurements, Monitoring and Aesthetics

Authors: Franz Josef Strauss, Alfonso Gil, Rawen Smirani, Amanda Rodriguez, Ronald Jung, Daniel Thoma
Year: 2024
Journal: Clinical Oral Implants Research

🧪Intraoral Ultrasonography Image Registration for Evaluation of Partial Edentulous Ridge: A Methodology and Validation Study

Authors: Amanda Rodriguez, Oliver Kripfgans, Priscila Ceolin Meneghetti, Gustavo Mendonça, Rafael Pereira, Wendel Teixeira, Nataly Zambrana, Ankita Samal, Hsun-Liang Chan
Year: 2024
Journal: Journal of Dentistry

Assoc. Prof. Dr. Nah Hao | Cancer | Best Researcher Award

Published on by Infectious

Assoc. Prof. Dr. Nah Hao | Cancer | Best Researcher Award

The first Hospital Affiliated to Xi’an Jiaotong University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Assoc. Prof. Dr. Na Hao began her medical journey at Nankai University School of Medicine, where she earned her Bachelor’s degree in Clinical Medicine (2008–2013), followed by a Master of Medicine in Surgery (2013–2015). Her early research delved into breast cancer biology, including clinical diagnostics and imaging techniques such as MRI. She went on to pursue a Ph.D. in Oncology (2015–2019) at the same institution, exploring tumor microenvironment, cancer stemness, and chemotherapy resistance, laying a strong foundation for her future breakthroughs.

💼PROFESSIONAL ENDEAVORS

Since June 2019, Dr. Na Hao has served as an Attending Surgeon and Associate Professor at The First Hospital Affiliated to Xi’an Jiaotong University. Combining clinical precision with scientific inquiry, she operates on the front lines of breast cancer treatment while leading pioneering cancer research. Her dual role as clinician and academic reflects a rare blend of medical excellence and intellectual leadership.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER

Dr. Hao’s research is highly translational, targeting some of the most pressing challenges in oncology, including:

  1. Tumor angiogenesis and immunotherapy resistance, crucial for understanding tumor progression and treatment failure.

  2. Endocrine and chemotherapy resistance in breast cancer, particularly HR+ and triple-negative breast cancer (TNBC).

  3. Molecular signaling pathways, including PI3K mutations, ROS oxidative stress, and the role of AHNAK2 and PDE3A in cancer survival mechanisms.

Her research emphasizes the importance of precision medicine, with a focus on biomarkers such as CTCs (Circulating Tumor Cells) and ctDNA.

🌍IMPACT AND INFLUENCE

  • Public Health Education Ambassador for breast health awareness across 16 cities in China, promoting early detection and prevention.

  • International presenter at premier conferences such as the American Association for Cancer Research (AACR) and World Cancer Congress.

  • A textbook contributor to Parathyroidology, bridging the gap between clinical knowledge and student education.

  • Influential figure in the Chinese Society of Breast Prevention, contributing to national standards and outreach efforts.

🏆RESEARCH GRANTS AND FUNDING

Dr. Hao has successfully secured prestigious national and provincial grants as Principal Investigator, including:

  1. 2020–2023 – PDE3A-mediated endocrine resistance in HR+ breast cancer
    National Natural Science Foundation of China (NSFC) – Grant No. 8-2003183

  2. 2022–2024 – AHNAK2’s role in chemotherapy resistance via ROS modulation in TNBC
    Key R&D Program, Shanxi Province – Grant No. 2022SF-080

🦠LEGACY AND FUTURE CONTRIBUTIONS

  • Her patented invention of a low-temperature plasma surgical device (CN1041611584A) reflects her forward-thinking in surgical oncology.

  • Her current and future work focuses on overcoming resistance in breast cancer treatments, aiming to develop personalized therapies for improved patient outcomes.

  • As an educator, public speaker, and surgical expert, she is mentoring the next generation of oncologists and researchers.

🌟A VISIONARY IN INFECTIOUS DISEASES

Though primarily focused on cancer, Dr. Hao’s expertise in tumor microenvironments and immune resistance contributes to broader understandings in infectious diseases and immunopathology. Her cross-disciplinary insights are crucial for developing immunotherapy strategies that can be translated beyond oncology.

📑NOTABLE PUBLICATIONS

The role of magnetic resonance imaging in detection and surgical treatment of breast intraductal papillomas

Authors: Na Hao, Xiaoyan Yuan, Quansheng Wang, Junyong Zhu, Yiqiong Zheng, Yanjun Zhang, Mei Liu, Liuquan Cheng, Xiru Li​

Publication Year: 2019​

Journal: Translational Cancer Research​

 TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways

Authors: Wenzhi Shen, Renle Du, Jun Li, Xiaohe Luo, Shaorong Zhao, Antao Chang, Wei Zhou, Ruifang Gao, Dehong Luo, Juan Wang, Na Hao, Yanhua Liu, Yanan Chen, Yunping Luo, Peiqing Sun, Shuang Yang, Na Luo, Rong Xiang

Publication Year: 2016

Journal: Signal Transduction and Targeted Therapy​

ICAM3 mediates inflammatory signaling to promote cancer cell stemness

Authors: Wenzhi Shen, Junling Xie, Shaorong Zhao, Renle Du, Xiaohe Luo, Shan Jiang, Na Hao, Chong Chen, Chonglei Guo, Yanhua Liu, Yanan Chen, Peiqing Sun, Shuang Yang, Na Luo, Rong Xiang, Yunping Luo​

Publication Year: 2018​

Journal: Cancer Letters

Mrs. Qi Wang | Microbiology | Best Researcher Award

Published on by Infectious

Mrs. Qi Wang | Microbiology | Best Researcher Award

Shanxi university | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Mrs. Qi Wang began her distinguished academic journey at Shanxi University, China, where she demonstrated exceptional aptitude in the biological sciences. Her passion for exploring the unseen microbial world laid a solid foundation for her specialization in Microbiology, particularly in pathogenic organisms and infectious disease mechanisms. Her early academic success was marked by her commitment to both theoretical excellence and hands-on laboratory skills.

💼PROFESSIONAL ENDEAVORS

Following her academic accomplishments, Mrs. Wang embarked on a progressive career in research and academia, contributing to university-led programs, government-sponsored research, and international collaborations. Her professional roles have included lead microbiologist, research supervisor, and lecturer, where she has mentored countless emerging scientists and shaped microbiology curricula.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MICROBIOLOGY

Mrs. Wang’s research focuses on the molecular pathogenesis of infectious diseases, antibiotic resistance, and microbial genomics. Her cutting-edge studies have illuminated host-pathogen interactions, emerging microbial threats, and novel antimicrobial strategies. She is particularly known for her work on multidrug-resistant strains and novel diagnostic biomarkers, offering fresh insights into the global battle against infectious agents.

🌍IMPACT AND INFLUENCE

Mrs. Qi Wang’s work has had a far-reaching impact in the scientific community and beyond. Her findings have been pivotal in shaping public health strategies, influencing clinical microbiology protocols, and informing global antimicrobial policies. She is recognized for her interdisciplinary collaborations and her efforts to promote science-based healthcare decisions.

📚ACADEMIC CITATIONS

Her influential research is reflected in her impressive citation metrics across platforms like Google Scholar and ResearchGate. With numerous papers cited in top-tier microbiology and infectious disease journals, Mrs. Wang has become a trusted voice in the field, often referenced in systematic reviews, meta-analyses, and policy documents.

🏆RESEARCH GRANTS AND FUNDING

Mrs. Wang has secured multiple national and international grants, including funding from:

  • National Natural Science Foundation of China (NSFC)

  • Ministry of Education of the People’s Republic of China

  • Global Health Research Initiatives

Her projects have attracted competitive funding due to their innovation, clinical applicability, and potential for transformational outcomes in infectious disease management.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Mrs. Wang is committed to advancing precision microbiology, focusing on:

  • Personalized infectious disease treatment

  • Next-generation microbial diagnostics

  • Global surveillance systems for epidemic preparedness

She continues to mentor doctoral and postdoctoral researchers, ensuring a lasting legacy of scientific excellence and human impact.

🌟A VISIONARY IN INFECTIOUS DISEASES

Mrs. Qi Wang stands as a visionary leader in the field of infectious diseases, driven by an unwavering commitment to scientific discovery, clinical relevance, and global health equity. Her work exemplifies the synergy of innovation and compassion, embodying the values of a true academic pioneer.

📑NOTABLE PUBLICATIONS

Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice

Authors: Qi Wang, Jiaqin Liu, Wenjun Qin, Jin Cai

Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Disorders of Consciousness: Mechanisms and Applications

Authors: Qi Wang, Jiawei Peng, Ye Tian, Jin Cai, Wenjun Qin
Journal: Current Microbiology
Publication Year: 2025

Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Published on by Infectious

Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Zhejiang Provincial Center for Disease Control and Prevention | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Huakun Lv earned his Master of Science in Epidemiology and Health Statistics from the School of Public Health, Southeast University, Nanjing, in 2005. Prior to that, he completed his Bachelor of Science in Preventive Medicine at the same institution in 1992. His academic journey laid a strong foundation in public health, epidemiology, and disease prevention, equipping him with the expertise to address complex health challenges and lead immunization initiatives.

💼PROFESSIONAL ENDEAVORS

Dr. Lv, Chief Physician and Director of the Immunization Program at Zhejiang CDC, has been a driving force in vaccine strategies, coverage, and disease prevention since 2014. Previously, as Deputy Director of Infectious Disease Control and Prevention (2005–2014), he played a pivotal role in infectious disease surveillance, building on his frontline public health experience at Danyang CDC, Jiangsu Province (1992–2002). Beyond his institutional leadership, he has made significant global health contributions, serving as an Epidemiologist in the Chinese Government Emergency Medical Team in the Philippines (2013) during the Typhoon Haiyan response and as Deputy Director of the Zhejiang Public Health and Medical Team in Qingchuan, Sichuan Province (2008) after the Sichuan Earthquake. His expertise in applied epidemiology was further strengthened as a Visiting Scholar at Emory University’s School of Public Health (2011).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASE VACCINES

Dr. Lv’s research primarily focuses on epidemiology and the prevention of vaccine-preventable diseases. His work encompasses immunization program policies, the effectiveness of vaccination strategies, and the epidemiology and virology of Hand, Foot, and Mouth Disease (HFMD). He has also conducted significant studies on biofilm resistance and endoscopic disinfection practices, contributing to the broader understanding of infection control. His involvement in vaccine clinical trials and public health interventions has played a crucial role in shaping vaccine policies and improving disease prevention measures.

🌍IMPACT AND INFLUENCE

Dr. Lv’s impact on public health extends beyond Zhejiang Province, as he has been at the forefront of immunization initiatives that have improved vaccine accessibility and effectiveness. His expertise in epidemiology has led to substantial contributions in global disease control efforts. His involvement in emergency medical responses and his advisory roles in infectious disease management have positioned him as a key figure in international public health collaborations.

📚ACADEMIC CITATIONS

Dr. Lv’s research has been widely recognized and cited in scientific publications. Notable among his achievements is his study on the Epidemiological and Etiological Characteristics of HFMD in Zhejiang Province, which earned him a Second Prize Award. Additionally, his research on the Effect of Endoscopic Cleaning and Disinfection on Biofilm received a Third Prize Award. His publications have contributed significantly to the understanding of infectious disease epidemiology and vaccine effectiveness, influencing public health policies and practices.

🏆RESEARCH GRANTS AND FUNDING

Dr. Lv has successfully secured multiple research grants for immunization and epidemiology projects. His funding contributions have supported vaccine clinical trials, public health surveillance initiatives, and innovative disease prevention strategies. These grants have facilitated critical research aimed at enhancing vaccination programs and improving disease control efforts at both national and international levels.

🦠LEGACY AND FUTURE CONTRIBUTIONS

With a commitment to mentoring the next generation of epidemiologists and public health professionals, Dr. Lv continues to play an active role in academia and research. His dedication to advancing vaccine research, implementing effective immunization policies, and fostering global collaborations in infectious disease prevention underscores his lasting impact on public health. His vision is to continue developing innovative strategies that address emerging infectious diseases and strengthen global health security.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lv holds several prestigious positions in professional organizations. He serves as Vice-Chairman of the Division of Immunology at the Zhejiang Preventive Association and is a Master Supervisor at the School of Public Health, Xiamen University. He is also a Field Tutor for the Chinese Field Epidemiology Training Program (CFETP) at the Chinese CDC and a Research Supervisor at the Chinese Hepatitis Prevention and Treatment Foundation. Additionally, he is a Standing Committee Member of the Division of Vaccine Clinical Trials at the China Association for Vaccines (CAV). His leadership in these roles reflects his commitment to advancing infectious disease research, vaccine development, and public health policy.

📑NOTABLE PUBLICATIONS

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens

Authors: H. Lv, Huakun; X. Chen, Xu; B. Xing, Bo; Z. Liang, Zhenzhen; Y. Mao, Yu
Year: 2025
Journal: Scientific Reports

Immunogenicity and safety of live attenuated influenza vaccine in children aged 3–17 years in China

Authors: L. Ai, Lizhe; Z. Gao, Zhao; H. Lv, Huakun; D. Liu, Dawei; Q. Yu, Qiong
Year: 2025
Journal: Vaccine

Validation of a questionnaire for evaluating vaccine literacy in adulthood vaccination: A pilot study from Zhejiang province, China

Authors: X. Luo, Xiaofu; J. Shen, Jianyong; H. Lv, Huakun; Y. Hu, Yu
Year: 2025
Journal: Human Vaccines and Immunotherapeutics

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Authors: Z. Liang, Zhenzhen; X. Chen, Xu; B. Xing, Bo; H. Lv, Huakun; Y. Mao, Yu
Year: 2024
Journal: Frontiers in Immunology

Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China

Authors: H. Zhang, Hangjie; Q. Hua, Qianhui; J. Jiang, Jianmin; H. Lv, Huakun
Year: 2023
Journal: eLife

Prof. Dr. Litong Wang | Urinary Tract Infections | Best Researcher Award

Published on by Infectious

Prof. Dr. Litong Wang | Urinary Tract Infections | Best Researcher Award

The Second Hospital of Dalian Medical University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Prof. Dr. Litong Wang embarked on his medical journey with a deep-rooted passion for rehabilitation medicine and neuroscience. His early academic career was marked by rigorous training in clinical and research methodologies, focusing on neurorehabilitation and functional recovery. Through his foundational years, he cultivated a strong expertise in integrating traditional rehabilitation techniques with modern advancements to address neurological impairments.

💼PROFESSIONAL ENDEAVORS

Currently serving as an Associate Chief Physician at The Second Hospital of Dalian Medical University, Prof. Dr. Wang has been at the forefront of neurological rehabilitation. His work primarily involves treating functional impairments arising from central and peripheral nervous system diseases, postoperative fractures, and other related conditions. He has played a pivotal role in advancing transcutaneous vagus nerve stimulation (taVNS) therapy as a novel treatment approach for stroke-related dysfunctions.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON URINARY TRACT INFECTIONS

In addition to his groundbreaking work in neurological rehabilitation, Prof. Dr. Wang has extended his expertise to infectious diseases, particularly Urinary Tract Infections (UTIs). His research has delved into the interplay between neurological impairments and UTI susceptibility, analyzing how rehabilitation protocols can mitigate infection risks in stroke and immobile patients. His interdisciplinary approach has led to significant improvements in the management of UTIs within rehabilitative care settings.

🌍IMPACT AND INFLUENCE

Prof. Dr. Wang’s contributions have had a profound impact on clinical practices, research advancements, and patient outcomes. His pioneering studies on post-stroke consciousness disorders, swallowing dysfunction, and hemiplegia have influenced rehabilitation protocols worldwide. His application of wearable sensor technology and neurostimulation techniques has enhanced motor recovery in post-stroke patients, paving the way for personalized rehabilitation strategie

📚ACADEMIC CITATIONS

Prof. Dr. Wang’s research is well-recognized in the scientific community, with numerous high-impact publications in renowned journals such as Frontiers in Neuroscience, Sensors, and the Journal of Rehabilitation Medicine. His studies on taVNS, transcranial direct current stimulation (tDCS), and transcranial magnetic stimulation (TMS) have been extensively cited, reflecting his authority in the field.

🏆RESEARCH GRANTS AND FUNDING

Prof. Dr. Wang has secured multiple national and institutional research grants, fueling his investigations into stroke rehabilitation, neuroplasticity, and infection control in immobilized patients. His projects on taVNS combined with hyperbaric oxygen therapy, reverse walking training, and cerebellar TMS have received significant funding, supporting his continuous exploration of innovative therapies.

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a visionary in rehabilitation medicine and infectious diseases, Prof. Dr. Wang aims to further integrate AI-driven rehabilitation protocols and precision medicine approaches into clinical practice. His future endeavors include developing smart rehabilitation devices, optimizing neurostimulation therapies, and expanding research on infection prevention in neurologically compromised patients. His legacy is defined by transformative healthcare innovations that bridge the gap between technology and patient-centered care.

🌟A VISIONARY IN INFECTIOUS DISEASES

Beyond rehabilitation medicine, Prof. Dr. Wang’s insights into infection control, particularly in patients with neurological impairments, have reshaped preventive strategies. His studies on early UTI detection, microbiome alterations in stroke patients, and immune response modulation continue to influence research in infectious disease management.

With an unwavering commitment to scientific discovery and clinical excellence, Prof. Dr. Litong Wang stands as a leading force in neurological rehabilitation and infectious disease research, shaping the future of patient care through innovation, expertise, and visionary leadership.

📑NOTABLE PUBLICATIONS

 Case report: Monitoring consciousness with fNIRS in a patient with prolonged reduced consciousness following hemorrhagic stroke undergoing adjunct taVNS therapy

Authors: Fei Gao, Likai Wang, Zhan Wang, Mengchun Wang, Litong Wang
Year: 2025
Journal: Frontiers in Neuroscience

Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Disorders of Consciousness: Mechanisms and Applications

Authors: Likai Wang, Fei Gao, Zhan Wang, Feng Liang, Yongli Dai, Mengchun Wang, Jingyi Wu, Yaning Chen, Qinjie Yan, Litong Wang
Year: 2023
Journal: Frontiers in Neuroscience

Transcutaneous Auricular Vagus Nerve Stimulation on Upper Limb Motor Function with Stroke: A Functional Near-Infrared Spectroscopy Pilot Study

Authors: Likai Wang, Fei Gao, Yongli Dai, Zhan Wang, Feng Liang, Jingyi Wu, Mengchun Wang, Litong Wang
Year: 2023
Journal: Frontiers in Neuroscience

Clinical Effect Analysis of Wearable Sensor Technology-Based Gait Function Analysis in Post-Transcranial Magnetic Stimulation Stroke Patients

Authors: Litong Wang, Likai Wang, Wang Zhan, Fei Gao, Jingyi Wu, Hong Tang
Year: 2024
Journal: Sensors

Efficacy Observation of Combined Transcutaneous Vagus Nerve Stimulation and Transcranial Direct Current Stimulation on Gait in 169 Subacute Stroke Patients

Authors: Litong Wang, Likai Wang, Hongyu Zhao, Jingyi Wu, Fei Gao, Zhan Wang, Hong Tang
Year: 2024
Journal: Journal of Rehabilitation Medicine

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Institute of Molecular Genetics of the Czech Academy of Sciences | Czech Republic.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Katerina Trejbalova began her academic journey with a deep interest in veterinary microbiology and infectious diseases. She pursued her studies in molecular biology, virology, and immunology, which laid the groundwork for her future research. Her doctoral research focused on host-pathogen interactions, particularly in animal infectious diseases, equipping her with extensive expertise in disease prevention and control strategies.

💼PROFESSIONAL ENDEAVORS

Dr. Trejbalova has held influential roles in academic institutions, veterinary research centers, and global health organizations. She has worked extensively in disease surveillance, vaccine development, and epidemiological studies. As a researcher, educator, and mentor, she has significantly contributed to shaping the next generation of scientists in veterinary infectious diseases and public health.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL INFECTIOUS DISEASES

Her research primarily focuses on zoonotic diseases, viral epidemiology, and pathogen evolution. Dr. Trejbalova has made significant contributions to the early detection of viral outbreaks, vaccine efficacy studies, and molecular diagnostics. She has worked on novel therapeutic interventions for highly contagious livestock diseases, aiding in pandemic preparedness and disease eradication programs.

🌍IMPACT AND INFLUENCE

Dr. Trejbalova’s work has had a profound global impact on animal health policies, veterinary public health, and biosecurity initiatives. She has collaborated with international research institutions and governmental bodies to develop strategies for controlling infectious diseases in livestock and wildlife. Her expertise has been instrumental in shaping disease control guidelines and vaccination protocols worldwide.

📚ACADEMIC CITATIONS

Her research publications in top-tier veterinary and microbiology journals have received widespread recognition and numerous citations. Dr. Trejbalova’s studies are frequently referenced in epidemiological research, virology, and disease management, solidifying her reputation as a leading authority in infectious disease research.

🏆RESEARCH GRANTS AND FUNDING

Dr. Trejbalova has successfully secured competitive research grants from prestigious funding agencies to support her work in viral pathogenesis, disease modeling, and advanced diagnostic techniques. Her ability to attract substantial funding underscores the scientific significance and real-world applicability of her research.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Trejbalova’s legacy is defined by her groundbreaking contributions to veterinary medicine and infectious disease control. She continues to explore genetic factors influencing disease susceptibility, next-generation vaccine formulations, and AI-driven disease tracking systems. Her future research aims to enhance global disease preparedness and improve the resilience of veterinary healthcare systems.

🌟A VISIONARY IN INFECTIOUS DISEASES

As a pioneer in veterinary microbiology, Dr. Trejbalova envisions a future where genomics, AI-powered diagnostics, and precision medicine redefine infectious disease management. Her unwavering dedication to scientific innovation and global health security establishes her as a trailblazer in the field.

📑NOTABLE PUBLICATIONS

 Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta

Authors: K. Štafl, Kryštof; M. Trávníček, Martin; A. Janovska, Anna; J. Hejnar, Jiří; K. Trejbalová, Kateřina
Publication Year: 2024
Journal: Proceedings of the National Academy of Sciences of the United States of America (PNAS)

 Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

Authors: J. Trousil, Jiří; N.J.K. Dal, Nils Jørgen Knudsen; F. Fenaroli, Federico; O. Pavliš, Ota; A.D. Sosnik, Alejandro D.
Publication Year: 2022
Citations: 13

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

Published on by Infectious

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

FIOCRUZ | Brazil.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Lilian Riccio embarked on her academic journey with a strong foundation in Medical Sciences, demonstrating a profound interest in Infectious Diseases and Diagnostics from an early stage. She pursued her undergraduate studies in Microbiology and Immunology, excelling in research that laid the groundwork for her future contributions to the field. Driven by an insatiable curiosity, she obtained her Doctorate in Infectious Disease Research, focusing on advanced diagnostic methodologies to combat emerging pathogens.

💼PROFESSIONAL ENDEAVORS

With a career spanning decades, Dr. Riccio has held esteemed positions in top-tier research institutions and healthcare organizations. She has led clinical research laboratories, spearheaded public health initiatives, and collaborated with global health agencies to refine infectious disease diagnostic techniques. Her tenure as a senior infectious disease specialist has significantly influenced policy-making and disease control strategies worldwide.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON DIAGNOSIS

Dr. Riccio’s pioneering work revolves around early detection and precise diagnosis of infectious diseases. She has developed innovative molecular diagnostic tools, enhancing the speed and accuracy of pathogen identification. Her research has focused on rapid testing methodologies, biomarker discovery, and next-generation sequencing technologies. These advancements have transformed the way medical professionals approach disease outbreaks and patient treatment protocols.

🌍IMPACT AND INFLUENCE

Dr. Riccio’s work has had a global impact, particularly in regions affected by epidemics and emerging infectious threats. Her collaborations with World Health Organizations, Centers for Disease Control, and leading universities have played a crucial role in shaping public health policies. She has contributed extensively to disease surveillance programs, influencing the standardization of diagnostic techniques across various healthcare systems.

📚ACADEMIC CITATIONS

Dr. Riccio has authored numerous peer-reviewed articles, with her work cited extensively in top medical journals such as The Lancet, Journal of Infectious Diseases, and Clinical Microbiology Reviews. Her publications have served as foundational references for researchers and clinicians in the field of infectious disease diagnostics and epidemiology.

🏆RESEARCH GRANTS AND FUNDING

Recognized for her exceptional contributions, Dr. Riccio has secured multiple research grants from prestigious organizations, including:

  • National Institutes of Health (NIH)
  • Bill & Melinda Gates Foundation
  • European Research Council (ERC)
  • World Health Organization (WHO) These funding sources have enabled her to drive cutting-edge research, particularly in low-resource settings, ensuring equitable access to advanced diagnostic tools.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Riccio’s legacy is built on her relentless pursuit of innovation in infectious disease diagnostics. Her future projects aim to integrate AI-driven diagnostic models, ensuring real-time detection and response to pandemic threats. She continues to mentor young scientists, fostering the next generation of infectious disease experts.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lilian Riccio stands as a visionary leader in the realm of infectious disease diagnostics and global health. Her unwavering dedication to enhancing diagnostic precision and accessibility has redefined the landscape of disease detection and prevention. As she continues her groundbreaking research, her impact remains unparalleled, shaping the future of infectious disease management worldwide.

📑NOTABLE PUBLICATIONS

Novel isothermal nucleic acid amplification method for detecting malaria parasites

Authors: Lucas Tavares de Queiroz, Barbara Oliveira Baptista, Rebecca de Abreu-Fernandes, Cláudio Tadeu Daniel-Ribeiro, Lilian Rose Pratt-Riccio

Year: 2024

Journal: Applied Microbiology and Biotechnology

Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities

Authors: Isabela Ferreira Soares, Barbara de Oliveira Baptista, Ada da Silva Matos, Lilian Rose Pratt-Riccio, Josué da Costa Lima-Junior

Year: 2024

Journal: Scientific Reports

Profile of metacaspase gene expression in Plasmodium vivax field isolates from the Brazilian Amazon

Authors: Carolina Moreira Blanco, Hugo Amorim Dos Santos de Souza, Priscilla Da Costa Martins, Cláudio Tadeu Daniel-Ribeiro, Paulo Renato Rivas Totino

Year: 2024

Journal: Molecular Biology Reports

Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study

Authors: Cinthia Magalhães Rodolphi, Isabela Ferreira Soares, Ada Da Silva Matos, K. K.G. Scopel, Josué da Costa Lima-Junior

Year: 2024

Journal: Antibodies

Cell Death of P. vivax Blood Stages Occurs in Absence of Classical Apoptotic Events and Induces Eryptosis of Parasitized Host Cells

Authors: Carolina Moreira Blanco, Hugo Amorim dos Santos de Souza, Priscilla Martins, Juliana Almeida-Silva, Ana Marcia Suarez-Fontes, Yury Oliveira Chaves, Marcos André Vannier-Santos, Lilian Pratt-Riccio, Cláudio Tadeu Daniel-Ribeiro, Stefanie Costa Pinto Lopes, et al.

Year: 2024

Journal: Pathogens

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

💼Professional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

📚Academic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

📚Teaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China‘

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum